These findings highlight the importance of tumour-specific biology in shaping the prognostic impact of these genes and underscore the need for further mechanistic studies to clarify how SV2B and CORO1C contribute to disease progression in distinct brain tumour subtypes. Here, SV2B is linked to neoplasm.